ADRX Stock: Price, Earnings History and SEC Filings
ADARx Pharmaceuticals, Inc. (ADRX) last traded at $17.00, down 4.76% on the latest session and down 14.7% over the past month.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ADRX earnings history
Earnings history is not available right now.
Latest SEC filings for ADRX
Insider filing activity
ADRX insiders filed 11 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
ADRX news
- Morgan Stanley Starts ADARx Pharmaceuticals (ADRX) at OverweightOct 20, 2026 · streetinsider.com
- UBS Starts ADARx Pharmaceuticals (ADRX) at BuyOct 20, 2026 · streetinsider.com
About ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. (ADRX) is a US-listed public company on Nasdaq. The SEC classifies its business as Pharmaceutical Preparations. It is incorporated in DE. Its fiscal year ends in December.